US Drug Pricing Patterns Before Loss of Exclusivity
Health Affairs Scholar
An analysis of US net cancer drug launch prices and clinical efficacy and certainty of evidence from 2008 to 2022
JMCP
Assessing variation in US payer coverage of anti–vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edema
Health Affairs Forefront
Bringing Systems Thinking To Drug Value Assessment
Health Affairs Forefront
Medicare Coverage Of Medical Technologies In A New Era
JMCP
Use of health technology assessments in specialty drug coverage decisions by US commercial health plans
Value in Health
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study
Value in Health
Does real option value influence oncologists' treatment recommendations? A survey of US oncologists
Archives of Dermatological Research
Impact on quality of life, health care access, and health care utilization of individuals with vitiligo: an analysis of the All of Us Research Program
